The results showed that ribosomal RNA processing protein 1B (RRP1B), a metastatic modulator in breast cancer [23,24], exhibited the most changes (up to 15-fold) after a three day-knockdown of DOCK1 in BT-549 cells (data not shown). Here, RRP1B is linked to breast carcinoma.